Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CLGN NYSE:NVRO NASDAQ:PROF NASDAQ:SKIN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCLGNCollPlant Biotechnologies$2.63+0.4%$2.40$1.31▼$5.00$33.32M1.6130,433 shs3,645 shsNVRONevro$5.85+0.1%$5.85$3.17▼$10.34$224.32M0.81818,428 shs753,602 shsPROFProfound Medical$4.09+1.2%$5.11$3.76▼$9.17$121.69M0.55150,602 shs62,501 shsSKINBeauty Health$2.63+4.0%$1.99$0.78▼$2.64$320.87M1.22840,195 shs2.02 million shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCLGNCollPlant Biotechnologies+0.38%-0.42%+3.14%+68.59%-47.50%NVRONevro0.00%0.00%0.00%0.00%+0.97%PROFProfound Medical+1.24%-0.49%-3.76%-39.76%-47.02%SKINBeauty Health+3.95%+12.88%+20.64%+71.90%+75.33%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCLGNCollPlant Biotechnologies$2.63+0.4%$2.40$1.31▼$5.00$33.32M1.6130,433 shs3,645 shsNVRONevro$5.85+0.1%$5.85$3.17▼$10.34$224.32M0.81818,428 shs753,602 shsPROFProfound Medical$4.09+1.2%$5.11$3.76▼$9.17$121.69M0.55150,602 shs62,501 shsSKINBeauty Health$2.63+4.0%$1.99$0.78▼$2.64$320.87M1.22840,195 shs2.02 million shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCLGNCollPlant Biotechnologies+0.38%-0.42%+3.14%+68.59%-47.50%NVRONevro0.00%0.00%0.00%0.00%+0.97%PROFProfound Medical+1.24%-0.49%-3.76%-39.76%-47.02%SKINBeauty Health+3.95%+12.88%+20.64%+71.90%+75.33%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCLGNCollPlant Biotechnologies 3.00Buy$11.50337.26% UpsideNVRONevro 2.00Hold$5.36-8.29% DownsidePROFProfound Medical 3.00Buy$11.00168.95% UpsideSKINBeauty Health 2.00Hold$2.63-0.19% DownsideCurrent Analyst Ratings BreakdownLatest CLGN, PROF, SKIN, and NVRO Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/21/2025CLGNCollPlant BiotechnologiesHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$11.008/20/2025CLGNCollPlant BiotechnologiesD. Boral CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$12.008/1/2025SKINBeauty HealthStifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$3.00 ➝ $4.00(Data available from 9/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCLGNCollPlant Biotechnologies$2.40M13.92N/AN/A$1.18 per share2.23NVRONevro$408.52M0.55N/AN/A$8.10 per share0.72PROFProfound Medical$11.84M10.40N/AN/A$2.01 per share2.03SKINBeauty Health$334.30M1.00$0.07 per share40.01$0.41 per share6.41Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCLGNCollPlant Biotechnologies-$16.61M-$1.13N/AN/AN/A-541.34%-94.08%-68.62%11/3/2025 (Estimated)NVRONevro-$92.21M-$3.05N/AN/AN/A-16.54%-23.52%-10.83%N/APROFProfound Medical-$27.82M-$1.46N/AN/AN/A-343.97%-89.74%-73.06%11/6/2025 (Estimated)SKINBeauty Health-$29.10M-$0.28N/AN/AN/A-6.13%-32.82%-2.96%11/11/2025 (Estimated)Latest CLGN, PROF, SKIN, and NVRO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/20/2025Q2 2025CLGNCollPlant Biotechnologies$0.29-$0.28-$0.57-$0.28$8.91 million$0.18 million8/14/2025Q2 2025PROFProfound Medical-$0.43-$0.52-$0.09-$0.52$4.75 million$2.21 million8/7/2025Q2 2025SKINBeauty Health-$0.06$0.03+$0.09$0.03$74.67 million$78.20 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCLGNCollPlant BiotechnologiesN/AN/AN/AN/AN/ANVRONevroN/AN/AN/AN/AN/APROFProfound MedicalN/AN/AN/AN/AN/ASKINBeauty HealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCLGNCollPlant BiotechnologiesN/A4.604.40NVRONevro0.675.023.76PROFProfound Medical0.118.537.07SKINBeauty Health4.915.154.15Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCLGNCollPlant Biotechnologies21.69%NVRONevro95.52%PROFProfound Medical47.86%SKINBeauty Health93.26%Insider OwnershipCompanyInsider OwnershipCLGNCollPlant Biotechnologies9.60%NVRONevro3.20%PROFProfound Medical1.52%SKINBeauty Health41.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCLGNCollPlant Biotechnologies7012.72 million11.50 millionOptionableNVRONevro1,09038.37 million36.27 millionOptionablePROFProfound Medical15030.12 million29.66 millionOptionableSKINBeauty Health1,030126.82 million74.83 millionOptionableCLGN, PROF, SKIN, and NVRO HeadlinesRecent News About These CompaniesHere’s what dermatologists are saying about your skin care routine: Keep it simple4 hours ago | msn.comSkin Care Tips: Don't hide the blackness of your knees, remove it from the roots! Know a very easy solutionSeptember 15 at 5:29 AM | msn.comHolistic, beauty, self-care wellness center opens new location in La JollaSeptember 14 at 7:27 PM | msn.comWhy Are Exosomes Suddenly in All Your Skin and Hair Serums?September 13 at 10:20 PM | msn.comTikTok is ruining your skin' as expert warns against 'overhyped' products going viral onlineSeptember 13 at 12:20 PM | msn.comJacobs Levy Equity Management Inc. Sells 671,987 Shares of The Beauty Health Company $SKINSeptember 13 at 3:41 AM | marketbeat.comWhy your skin barrier might just be your most important beauty featureSeptember 12, 2025 | msn.comBeauty sleep isn’t a myth – a sleep medicine expert explains how rest keeps your skin healthy and youthfulSeptember 12, 2025 | sfgate.comHerbal beauty expert Shahnaz Husain shares top 7 anti ageing face masks for younger looking skin: Banana, lemon, matchaSeptember 11, 2025 | msn.comHow smoking affects the skin: 16 side effects and risks you should knowSeptember 11, 2025 | timesofindia.indiatimes.comWhy BeautyHealth (SKIN) Stock Is Trading Lower TodaySeptember 10, 2025 | msn.comMichelle Monaghan, 49, on Skincare, Makeup Trailer Hacks, and the Beauty of AgingSeptember 10, 2025 | msn.comA Hydrating Toner Is My Beauty Editor Secret to Ridiculously Glowy Skin—And Most People Skip ItSeptember 9, 2025 | msn.comBeyond the 10-Step Routine: The Real Korean Beauty Secrets for Flawless SkinSeptember 9, 2025 | msn.comGlass Skin 2.0: Korean Beauty Trend for Radiant Skin in 2025September 9, 2025 | msn.comHealth Y Sol Brings Back the Ancient Art of Tallow Soap for Healthy SkinSeptember 9, 2025 | miamiherald.comMMULTIMEDIA UPDATE -- Hydrafacial Launches Inaugural Hydrafacial Advisory Councils & Ambassador Network to Fuel Next-Era Innovation and GrowthSeptember 9, 2025 | globenewswire.comThe Beauty Health Company Launches Hydrafacial Advisory Councils and Ambassador Network to Enhance Provider Engagement and InnovationSeptember 9, 2025 | quiverquant.comQHydrafacial Launches Inaugural Hydrafacial Advisory Councils & Ambassador Network to Fuel Next-Era Innovation and GrowthSeptember 9, 2025 | globenewswire.comMarie Claire UK Skin Awards 2025: Meet the Visionary Judges Defining the Best in BeautySeptember 8, 2025 | msn.comFrom Kitchen To Skincare: 10 Herbs And Spices That Naturally Enhance Skin Health And BeautySeptember 7, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesTake Profits Now: 3 Overbought Stocks Primed for a PullbackBy Dan Schmidt | August 25, 2025Buffett’s Wisdom Could Spell Trouble for Palantir ShortsBy Chris Markoch | August 26, 2025What to Watch for From D-Wave Now That Earnings Are DoneBy Nathan Reiff | September 2, 2025DLocal Stock Soars 43% After Earnings Beat and Raised GuidanceBy Ryan Hasson | August 19, 2025Time to Take Profits on Strategy Stock? 3 Reasons You ShouldBy Gabriel Osorio-Mazilli | September 1, 2025CLGN, PROF, SKIN, and NVRO Company DescriptionsCollPlant Biotechnologies NASDAQ:CLGN$2.63 +0.01 (+0.38%) Closing price 09/15/2025 03:57 PM EasternExtended Trading$2.62 0.00 (-0.19%) As of 09/15/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds; as well as develops injectable breast implants and 3D bioprinted regenerative soft tissue matrix for use in breast reconstruction procedures. It has collaboration agreements with Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; International Society for Biofabrication; AbbVie; and STEMCELL Technologies. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. The company was founded in 2004 and is headquartered in Rehovot, Israel.Nevro NYSE:NVRONevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG) system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems. It also offers Senza HFX iQ platform, that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system; and provides sacroiliac joint fusion devices under NevroV1, NevroFix, and NevroPro brands. In addition, the company offers surpass surgical and percutaneous leads. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is headquartered in Redwood City, California.Profound Medical NASDAQ:PROF$4.09 +0.05 (+1.24%) Closing price 09/15/2025 03:59 PM EasternExtended Trading$4.12 +0.03 (+0.73%) As of 04:53 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.Beauty Health NASDAQ:SKIN$2.63 +0.10 (+3.95%) Closing price 09/15/2025 04:00 PM EasternExtended Trading$2.64 +0.00 (+0.19%) As of 05:14 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir’s Commercial Growth Story Is Just Getting Started The Applied Digital Breakout Is Only the Beginning $100 Million Buyback in Upwork Stock Follows a Strong Quarter Reddit Hits Record Highs: Why Wall Street Is Taking Notice Royal Caribbean's 33% Dividend Hike Signals Deeper Growth FuelCell Energy's Stock: Is a Fundamental Breakout Underway? After a Strong Wall Street Debut, Klarna's Real Work Begins MarketBeat Week in Review – 09/08 - 09/12 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
